Asia-Pacific Rapid Diagnostic Tests (RDT) Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Dec 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 309
  • No of Figures: 65

Asia-Pacific Rapid Diagnostic Tests (RDT) Market, By Product Type (Consumables and Kits, Instruments and Others), Mode (Professional Rapid Diagnostic Test Product and Over-The-Counter [OTC] Rapid Diagnostic Test Product), Technology (PCR-Based, Flow-Through Assays, Lateral Flow Immunochromatographic Assays, Agglutination Assay, Microfluidics, Substrate Technology and Others), Modality (Laboratory Based Test and Non-Laboratory Based Test), Age Group (Adult and Pediatric), Test Type (Determining Confirmation, Serological Testing and Viral Sequencing), Approach (In-Vitro Diagnostic, Molecular Diagnostic), Specimen (Swab, Blood, Urine, Saliva, Sputum and Others), Application (Infectious Disease Testing, Glucose Monitoring, Cardiology Testing, Oncology Testing, Cardiometabolic Testing, Drugs-of-Abuse Testing, Pregnancy & Fertility Testing, Toxicology Testing, Others), End User (Hospital & Clinic, Diagnostic Laboratory, Home Care Setting, Research and Academic Institutes and Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific), Industry Trends and Forecast to 2029  

Asia-Pacific Rapid Diagnostic Tests (RDT) Market Market Analysis and Insights: Asia-Pacific Rapid Diagnostic Tests (RDT) Market

Asia-Pacific rapid diagnostic tests (RDT) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.2% in the forecast period of 2022 to 2029 and is expected to reach USD 24,632.40 million by 2029 from USD  11,854.32 million in 2021. The rise in incidence in chronic diseases and technological advancements in the Asia-Pacific rapid diagnostic tests (RDT) market are likely to be the major drivers which propel the demand in the forecast period.

The rapid diagnostic tests, also called rapid tests, are easy-to-use tests that offer quick results, usually in less than 20 minutes. Unlike other standard and conventional tests, where the diagnosis and sampling are sent to the laboratory, the results obtained from rapid diagnostic test kits are provided at the point of care. The point of care is a place where the patients get cured. The point of care can be a provider's office, a clinic, or a patient's own house.

The RDTs are applicable for diagnosing and testing infectious diseases such as COVID-19, cardiology diseases, oncology, pregnancy, fertility testing, toxicology testing, drugs-of-abuse testing, cardiometabolic testing, and glucose monitoring.

The factors expected to drive the Asia-Pacific rapid diagnostic tests (RDT) market are the increase in incidence in chronic diseases, rise in geriatric population, technological developments in the rapid diagnostic tests. However, the factors which are expected to restrain the market are the rise in the cost of rapid diagnostics, product recalls faced in rapid diagnostic tests, and lack of awareness about the use of rapid diagnostics. Moreover, the strategic initiatives by market players and the rise in healthcare expenditure are expected to create opportunities for the Asia-Pacific rapid diagnostic tests (RDT) market growth. However, the need for skilled labor for sample collection and the late approval associated with product launches may significantly challenge market growth.

The Asia-Pacific rapid diagnostic tests (RDT) market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Rapid Diagnostic Tests (RDT) Market Asia-Pacific Rapid Diagnostic Tests (RDT) Market Scope and Market Size

The Asia-Pacific rapid diagnostic tests (RDT) market is categorized into eleven notable segments based on product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application area's difference in your target markets.

  • On the basis of product type, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into consumables and kits, instruments, and others. In 2022, the consumables and kits segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the easy use and availability of consumables and kits in the Asia-Pacific region.
  • On the basis of mode, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into professional rapid diagnostic test product, and over-the-counter [OTC] rapid diagnostic test product. In 2022, the professional rapid diagnostic test product segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the increased use in points of care, such as homes.
  • On the basis of technology, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into PCR-based, flow-through assays, lateral flow immunochromatographic assays, agglutination assay, microfluidics, substrate technology, and others. In 2022, the PCR-based segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to reliability and delivery of results at a faster rate.
  • On the basis of modality, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into laboratory based test and non-laboratory based test. In 2022, the laboratory based test segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the better laboratory infrastructure in Japan, Malaysia, and other regions of Asia-Pacific.
  • On the basis of age group, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into adult and pediatric. In 2022, the adult segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the increase in the geriatric population in China and Japan and the rise in mortality cases due to malaria.
  • On the basis of test type, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into determining confirmation, serological testing, and viral sequencing. In 2022, the determining confirmation segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market as it is necessary to determine the cause of infectious diseases since the diagnosis by the RDTs provides confirmed infectious disease results.
  • On the basis of approach, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into in-vitro diagnostic and molecular diagnostic. In 2022, the in-vitro diagnostic segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to its ability to detect infectious diseases such as COVID-19.
  • On the basis of specimen, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into swab, blood, urine, saliva, sputum, and others. In 2022, the swab segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market, due to advancements in serology, for the collection of swabs.
  • On the basis of application, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into infectious disease testing, glucose monitoring, cardiology testing, oncology testing, cardiometabolic testing, drugs-of-abuse testing, pregnancy & fertility testing, toxicology testing, and others. In 2022, the infectious disease testing segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the rise in cases of chronic infectious disease and government funding for the use of rapid diagnostics.
  • On the basis of end user, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into hospital & clinic, diagnostic laboratory, home care setting, research and academic institutes, and others. In 2022, the hospital & clinic segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the availability of advanced rapid diagnostic test (RDT) kits in hospitals and better facilities for the care of patients in the Asia-Pacific region.
  • On the basis of distribution channel, the Asia-Pacific rapid diagnostic tests (RDT) market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the Asia-Pacific rapid diagnostic tests (RDT) market due to the rise in contractual agreements between manufacturers and distributors for rapid diagnostic tests.

 Asia-Pacific Rapid Diagnostic Tests (RDT) Market Country Level Analysis

The Asia-Pacific rapid diagnostic tests (RDT) market is analyzed, and market size information is provided by country, product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel.

The countries covered in the Asia-Pacific rapid diagnostic tests (RDT) market report are Japan, China, India, South Korea, Australia, Singapore, Indonesia, Philippines, and the Rest of Asia-Pacific.

Asia-Pacific is expected to grow with the highest CAGR in the forecast period as the demand for rapid diagnostic tests (RDT) products increases rapidly with urbanization and laboratory automation. China is expected to dominate in the Asia-Pacific rapid diagnostic tests (RDT) market as it is one of the leading countries to inculcate rapid diagnostic tests (RDT).

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

Growth Potential for Rapid Diagnostic Tests (RDT) in Emerging Economies and Strategic Initiatives by Market Players Create New Opportunities in the Asia-Pacific Rapid Diagnostic Tests (RDT) Market 

The Asia-Pacific rapid diagnostic tests (RDT) market also provides you with detailed market analysis for every country growth in a particular industry with rapid diagnostic tests (RDT) sales, the impact of advancement in the rapid diagnostic tests (RDT), and changes in regulatory scenarios with their support for the Asia-Pacific rapid diagnostic tests (RDT) market. The data is available for the historical period 2011 to 2020.

Competitive Landscape and Asia-Pacific Rapid Diagnostic Tests (RDT) Market Share Analysis

The Asia-Pacific rapid diagnostic tests (RDT) market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the Asia-Pacific rapid diagnostic tests (RDT) market.

Some of the major companies in the Asia-Pacific rapid diagnostic tests (RDT) market are Abbott, Danaher, Fujirebio (A Subsidiary of H.U. Group), AdvaCare Pharma, Access Bio, Cardinal Health, Bio-Rad Laboratories, Inc., BD, F. Hoffmann-La Roche Ltd, bioMérieux SA, InBios International, Inc., Luminex Corporation. A DiaSorin Company, Gnomegen LLC, QIAGEN, Quidel Corporation, Chembio Diagnostics Systems, Inc., Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG), PerkinElmer Inc., Sekisui Diagnostics, PTS Diagnostics, Werfen, Nova Biomedical, Trinity Biotech, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players and new technological advancements for rapid diagnostic tests (RDT) are bridging the gap for diagnosis and treatment.

For instance,

  • In August 2021, Cardinal Health partnered with Abbott and Quidel Corporation to commercialize the over-the-counter (OTC) rapid COVID-19 tests. The partnership would allow Cardinal Health to expand Cardinal Health's COVID-19 testing and surveillance offerings and be able to access Quidel's QuickVue At-Home OTC COVID-19 Test and Abbott's BinaxNOW COVID-19 Antigen Self-Test, which allow the patients to perform tests without prescription easily
  • In November 2021, the Quidel Corporation had received emergency approval from the Food and Drug Administration (FDA) for the novel Sofia Q Rapid Antigen Test Device. The approval on an emergent basis was to add the Sofia Q in its latest addition of product range, along with Sofia and Sofia 2 line of Fluorescent Immunoassay Analyzers (FIA). The approval received would allow the Sofia Q rapid antigen test device to be used in telemedicine and home markets

Collaboration, joint ventures, and other strategies by the market players enhance the company in the Asia-Pacific rapid diagnostic tests (RDT) market, which also benefits the organization to improve their offering for the market.

Customization Available: Asia-Pacific Rapid Diagnostic Tests (RDT) Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.  


SKU-

TABLE 1 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 ASIA PACIFIC CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 ASIA PACIFIC CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 4 ASIA PACIFIC IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 ASIA PACIFIC ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 ASIA PACIFIC RT/PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 7 ASIA PACIFIC INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 ASIA PACIFIC INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC PROFESSIONAL IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC OVER-THE-COUNTER [OTC] IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC PCR-BASED IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC FLOW-THROUGH ASSAYS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAYS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC AGGLUTINATION ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC SUBSTRATE TECHNOLOGY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC LABORATORY BASED TEST IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 ASIA PACIFIC NON-LABORATORY BASED TEST IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 26 ASIA PACIFIC ADULT IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 ASIA PACIFIC PEDIATRIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 ASIA PACIFIC VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 35 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 36 ASIA PACIFIC IN-VITRO DIAGNOSTIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 ASIA PACIFIC MOLECULAR DIAGNOSTIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 39 ASIA PACIFIC SWAB IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 ASIA PACIFIC BLOOD IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 ASIA PACIFIC URINE IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 ASIA PACIFIC SALIVA IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 ASIA PACIFIC SPUTUM IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 ASIA PACIFIC OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 46 ASIA PACIFIC INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 ASIA PACIFIC INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 48 ASIA PACIFIC GLUCOSE MONITORING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 ASIA PACIFIC CARDIOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 ASIA PACIFIC ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 ASIA PACIFIC ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 52 ASIA PACIFIC CARDIOMETABOLIC TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 53 ASIA PACIFIC DRUGS-OF-ABUSE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 54 ASIA PACIFIC PREGNANCY & FERTILITY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 ASIA PACIFIC TOXICOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 56 ASIA PACIFIC OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 57 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 58 ASIA PACIFIC HOSPITAL & CLINIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 59 ASIA PACIFIC DIAGNOSTIC LABORATORY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 60 ASIA PACIFIC HOME CARE SETTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 61 ASIA PACIFIC RESEARCH AND ACADEMIC INSTITUTES IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 62 ASIA PACIFIC OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 63 ASIA PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 64 ASIA PACIFIC DIRECT TENDER IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 65 ASIA PACIFIC RETAIL SALES IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 66 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 67 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 68 ASIA-PACIFIC CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 69 ASIA-PACIFIC IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 70 ASIA-PACIFIC ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 71 ASIA-PACIFIC RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 72 ASIA-PACIFIC INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 73 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 74 ASIA-PACIFIC LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 75 ASIA-PACIFIC MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 76 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 77 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 78 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 79 ASIA-PACIFIC DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 80 ASIA-PACIFIC SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 81 ASIA-PACIFIC VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 82 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 83 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 84 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 ASIA-PACIFIC INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 ASIA-PACIFIC ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 88 ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 89 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 90 CHINA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 91 CHINA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 92 CHINA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 93 CHINA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 94 CHINA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 95 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 96 CHINA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 97 CHINA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 98 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 99 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 100 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 101 CHINA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 102 CHINA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 103 CHINA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 104 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 105 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 106 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 CHINA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 CHINA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 110 CHINA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 111 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 112 JAPAN CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 113 JAPAN IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 114 JAPAN ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 115 JAPAN RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 116 JAPAN INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 117 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 118 JAPAN LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 119 JAPAN MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 120 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 121 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 122 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 123 JAPAN DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 124 JAPAN SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 125 JAPAN VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 126 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 127 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 128 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 JAPAN INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 JAPAN ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 132 JAPAN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 133 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 134 SOUTH KOREA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 135 SOUTH KOREA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 136 SOUTH KOREA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 137 SOUTH KOREA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 138 SOUTH KOREA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 139 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 140 SOUTH KOREA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 141 SOUTH KOREA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 142 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 143 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 144 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 145 SOUTH KOREA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 146 SOUTH KOREA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 147 SOUTH KOREA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 148 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 149 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 150 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 151 SOUTH KOREA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 152 SOUTH KOREA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 153 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 154 SOUTH KOREA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 155 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 156 INDIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 157 INDIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 158 INDIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 159 INDIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 160 INDIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 161 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 162 INDIA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 163 INDIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 164 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 165 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 166 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 167 INDIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 168 INDIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 169 INDIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 170 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 171 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 172 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 173 INDIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 174 INDIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 175 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 176 INDIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 177 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 178 AUSTRALIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 179 AUSTRALIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 180 AUSTRALIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 181 AUSTRALIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 182 AUSTRALIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 183 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 184 AUSTRALIA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 185 AUSTRALIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 186 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 187 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 188 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 189 AUSTRALIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 190 AUSTRALIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 191 AUSTRALIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 192 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 193 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 194 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 195 AUSTRALIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 196 AUSTRALIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 197 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 198 AUSTRALIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 199 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 200 SINGAPORE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 201 SINGAPORE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 202 SINGAPORE ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 203 SINGAPORE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 204 SINGAPORE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 205 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 206 SINGAPORE LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 207 SINGAPORE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 208 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 209 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 210 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 211 SINGAPORE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 212 SINGAPORE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 213 SINGAPORE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 214 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 215 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 216 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 217 SINGAPORE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 218 SINGAPORE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 219 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 220 SINGAPORE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 221 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 222 THAILAND CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 223 THAILAND IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 224 THAILAND ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 225 THAILAND RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 226 THAILAND INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 227 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 228 THAILAND LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 229 THAILAND MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 230 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 231 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 232 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 233 THAILAND DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 234 THAILAND SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 235 THAILAND VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 236 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 237 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 238 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 239 THAILAND INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 240 THAILAND ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 241 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 242 THAILAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 243 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 244 MALAYSIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 245 MALAYSIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 246 MALAYSIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 247 MALAYSIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 248 MALAYSIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 249 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 250 MALAYSIA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 251 MALAYSIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 252 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 253 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 254 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 255 MALAYSIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 256 MALAYSIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 257 MALAYSIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 258 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 259 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 260 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 261 MALAYSIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 262 MALAYSIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 263 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 264 MALAYSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 265 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 266 INDONESIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 267 INDONESIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 268 INDONESIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 269 INDONESIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 270 INDONESIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 271 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 272 INDONESIA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 273 INDONESIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 274 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 275 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 276 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 277 INDONESIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 278 INDONESIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 279 INDONESIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 280 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 281 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 282 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 283 INDONESIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 284 INDONESIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 285 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 286 INDONESIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 287 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 288 PHILIPPINES CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 289 PHILIPPINES IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 290 PHILIPPINES ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 291 PHILIPPINES RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 292 PHILIPPINES INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 293 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 294 PHILIPPINES LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 295 PHILIPPINES MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 296 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 297 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 298 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 299 PHILIPPINES DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 300 PHILIPPINES SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 301 PHILIPPINES VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 302 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 303 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 304 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 305 PHILIPPINES INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 306 PHILIPPINES ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 307 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 308 PHILIPPINES RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 309 REST OF ASIA-PACIFIC RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions